Training women on emotion regulation after cardiac events
Satisfaction With eMotion in a Diverse Group of Women
This study is testing a program that teaches women how to manage their emotions after a heart event to see if it helps them feel more satisfied and supported in their recovery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Indiana University Academic / other |
| Locations | 1 site (Indianapolis, Indiana) |
| Trial ID | NCT06404866 on ClinicalTrials.gov |
What this trial studies
This study evaluates the satisfaction of women from diverse backgrounds with the eMotion intervention, which provides training on emotion regulation skills tailored for those who have experienced a first major cardiac event. Over a 10-week period, participants engage in weekly lessons that include personalized content and virtual discussions with study team members. The intervention aims to address the unique emotional needs of these women, particularly in light of social determinants of health that may affect their recovery. Feedback from participants will be used to further refine the intervention for better accessibility and relevance.
Who should consider this trial
Good fit: Ideal candidates are women who have experienced a first major cardiac event and exhibit mild symptoms of depression or anxiety.
Not a fit: Patients who do not understand English or are in palliative care or hospice may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could enhance emotional well-being and recovery for women after cardiac events.
How similar studies have performed: While there have been studies on emotion regulation interventions, this specific approach tailored for diverse women post-cardiac event is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * First-time major cardiac event as documented in the medical record * Lives independently * Has at least mild symptoms of depression (determined by Patient Health Questionnaire-8 \[PHQ-8\] scores of 5 or greater) and/or at least mild symptoms of anxiety (determined by the General Anxiety Disorder \[GAD-7\] scores of 5 or greater). Exclusion Criteria: * Does not understand both spoken and written English * In palliative care or hospice * Legally blind
Where this trial is running
Indianapolis, Indiana
- Eskenazi Hospital — Indianapolis, Indiana, United States (Recruiting)
Study contacts
- Principal investigator: Kelly L Wierenga, PhD — Indiana University School of Medicine
- Study coordinator: Kelly L Wierenga, PhD
- Email: kwiereng@iu.edu
- Phone: 317-274-8091
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.